Antibacterial drugs are majorly used in treatment and prevention of infectious diseases and are categorized into seven major classes based on their molecular structure namely, aminoglycosides, β-Lactams, tetracyclines, sulfonamides, quinolones, macrolides, and phenicols.
for more details, read https://bit.ly/3rxRrQZ
Moreover, increasing approval and launch of new antibacterial drugs is also expected to aid in growth of the market. For instance, in November 2019, Shionogi Inc. received the U.S. Food and Drug Administration approval for its Fetroja (cefiderocol), an antibacterial drug for treatment of complicated urinary tract infections in patients 18 years of age or older.